Ganglioside expression in lung cancer cell lines

被引:58
|
作者
Fuentes, R [1 ]
Allman, R [1 ]
Mason, MD [1 ]
机构
[1] VELINDRE HOSP,RES DEPT,CARDIFF CF4 7XL,S GLAM,WALES
关键词
lung cancer; cell lines; gangliosides; alpha v integrin receptor;
D O I
10.1016/S0169-5002(97)00049-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gangliosides are complex glycolipid constituents of cell membranes. They are involved in many biological functions including cell-cell recognition, cell-matrix attachment, cell growth and cell differentiation. Analysis of tumour associated gangliosides may aid in the characterisation of tumour cells and their degree of malignant transformation. We have characterised a total of eight lung cancer cell lines (four small cell and four non-small cell lung cancer) with respect to ganglioside and alpha v integrin receptor expression. Ganglioside GD3 was detected using the monoclonal antibody R24. Ganglioside GM1 was detected using the beta-subunit of cholera toxin. Ganglioside 9-O-acetyl GD3 and the alpha v integrin receptor were measured using commercially available monoclonal antibodies. Our results indicate that small cell lung cancer cell lines express significant levels of GD3 and 9-O-acetyl GD3. Ganglioside GM1 and alpha v integrin receptor were not specific to any histological subtype. The expression of ganglioside GM1 and GD3 was independent of cell-cycle phase. We conclude that GD3 and 9-O-acetyl GD3 expression may be additional markers of the Small Cell Lung Cancer phenotype, but their significance is unknown. Therefore a characteristic ganglioside pattern cannot be defined according to histological subtype. av integrin receptor expression is not unique to cells expressing GD3. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:21 / 33
页数:13
相关论文
共 50 条
  • [1] Differential expression of inflammasomes in lung cancer cell lines and tissues
    Kong, Hui
    Wang, Yanli
    Zeng, Xiaoning
    Wang, Zailiang
    Wang, Hong
    Xie, Weiping
    TUMOR BIOLOGY, 2015, 36 (10) : 7501 - 7513
  • [2] Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines
    Chen, Qing-Yong
    Jiao, De-Min
    Yao, Qing-Hua
    Yan, Jie
    Song, Jia
    Chen, Fang-Yuan
    Lu, Guo-Hua
    Zhou, Jan-Ying
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (05) : 1561 - 1568
  • [3] In vitro PET evaluations in lung cancer cell lines
    Xing, T
    Wu, F
    Brodin, O
    Fasth, KJ
    Långström, B
    Bergström, M
    ANTICANCER RESEARCH, 2000, 20 (3A) : 1375 - 1380
  • [4] Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients
    Fukunaga, Y
    Bandoh, S
    Fujita, J
    Yang, Y
    Ueda, Y
    Hojo, S
    Dohmoto, K
    Tojo, Y
    Takahara, J
    Ishida, T
    LUNG CANCER, 2002, 38 (01) : 31 - 38
  • [5] Effects of Navelbine and Docetaxel on Gene Expression in Human Lung Cancer Cell Lines
    Shi, Guangyue
    Cai, Li
    Jiang, Wei
    Sui, Guangjie
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2011, 61 (03) : 665 - 671
  • [6] Analysis of Fas and Fas Ligand Expression and Function in Lung Cancer Cell Lines
    Li, Yin
    Zheng, Shi-ying
    Jiang, Dong
    Ge, Jin-feng
    2010 3RD INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI 2010), VOLS 1-7, 2010, : 106 - 112
  • [7] Analysis of Fas and Fas ligand expression and function in lung cancer cell lines
    Kawasaki, M
    Kuwano, K
    Nakanishi, Y
    Hagimoto, N
    Takayama, K
    Pei, XH
    Maeyama, T
    Yoshimi, M
    Hara, N
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (05) : 656 - 663
  • [8] Effects of Navelbine and Docetaxel on Gene Expression in Human Lung Cancer Cell Lines
    Guangyue Shi
    Li Cai
    Wei Jiang
    Guangjie Sui
    Cell Biochemistry and Biophysics, 2011, 61 : 665 - 671
  • [9] Regulation of nuclear oncogenes expressed in lung cancer cell lines
    Sabichi, AL
    Birrer, MJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, : 218 - 227
  • [10] Lack of racial and ethnic diversity in lung cancer cell lines contributes to lung cancer health disparities
    Leon, Christopher
    Manley Jr, Eugene
    Neely, Aaron M.
    Castillo, Jonathan
    Correa, Michele Ramos
    Velarde, Diego A.
    Yang, Minxiao
    Puente, Pablo E.
    Romero, Diana I.
    Ren, Bing
    Chai, Wenxuan
    Gladstone, Matthew
    Lamango, Nazarius S.
    Huang, Yong
    Offringa, Ite A.
    FRONTIERS IN ONCOLOGY, 2023, 13